Category: Stock
-
UK regular wage growth cools, in line with BoE’s view of economy By Reuters
LONDON (Reuters) -British wage growth excluding bonuses fell in the third quarter to its lowest level in over two years, official data showed on Tuesday, something that will give the Bank of England confidence that inflation pressures will continue to ease as it hopes. British average weekly earnings, excluding bonuses, were 4.8% higher in the…
-
Renn fund’s president Murray Stahl buys $2,554 in common stock By
Murray Stahl, President and CEO of RENN Fund, Inc. (NYSE:RCG), recently acquired a significant amount of the company’s common stock. According to a recent SEC filing, Stahl purchased a total of 1,228 shares at a price of $2.08 per share, amounting to a total investment of $2,554. The transactions, which occurred on October 15, 2024,…
-
Israel stocks higher at close of trade; TA 35 up 0.78% By
– Israel stocks were higher after the close on Monday, as gains in the , and sectors led shares higher. At the close in Tel Aviv, the rose 0.78% to hit a new all time high. The best performers of the session on the were Azrieli Group Ltd (TASE:), which rose 3.03% or 770.00 points…
-
SpaceX catches giant Starship booster in fifth flight test By Reuters
By Joey Roulette (Reuters) -SpaceX in its fifth Starship test flight on Sunday returned the rocket’s towering first stage booster back to its Texas launch pad for the first time using giant metal arms, achieving another novel engineering feat in the company’s push to build a reusable moon and Mars vehicle. The rocket’s first stage…
-
Israel orders evacuation of more southern Lebanese towns amid rising displacement By Reuters
By Amina Ismail and Ahmed Tolba BEIRUT/CAIRO (Reuters) -Israel’s military ordered residents of 23 southern Lebanese villages on Saturday to evacuate to areas north of the Awali River, which flows from the western Bekaa Valley into the Mediterranean. The order, communicated via a military statement, mentions villages in southern Lebanon that have been recent targets…
-
US-based China ETFs get bumper influx, some investors optimistic tide is turning By Reuters
By Suzanne McGee (Reuters) – Investors flooded U.S.-based exchange-traded funds (ETFs) that target Chinese markets with $5.2 billion in new assets in the past week when mainland China’s financial markets were shut for a national holiday, and some asset managers are hopeful the optimism will be enduring. The influx came after an initial package of…
-
bioAffinity Technologies secures shareholder nod for warrant exercise By
SAN ANTONIO, TX – bioAffinity Technologies, Inc. (NASDAQ:BIAF), a commercial physical and biological research services company, announced today that its shareholders have approved the issuance of shares upon the exercise of warrants. This decision came during the 2024 Special Meeting of Stockholders held on October 2, 2024. The company, which is based in San Antonio,…
-
Two ceremonies show Israel’s conflicting narratives over Oct. 7 By Reuters
By Rami Amichay and Ari Rabinovitch TEL AVIV (Reuters) – One commemoration of the Oct. 7 assault on southern Israel will be a live, public ceremony to be held at a large venue in Tel Aviv. The other on Monday, will be a pre-recorded televised tribute that leaves little to chance. The first is organized…
-
BCA says investors should fade the real estate rally By
— BCA Research told investors in a recent note to take a cautious approach toward the recent rally in the real estate sector, which has been the best-performing sector in the , with distressed sectors like Office REITs leading the charge. However, BCA analysts warn that this momentum may not be sustainable. While real estate’s…
-
Aldeyra Therapeutics stock affirmed at Outperform on NDA submission By
On Thursday, Oppenheimer maintained its positive stance on Aldeyra Therapeutics (NASDAQ:) shares, reiterating an Outperform rating and a price target of $12.00. The firm’s endorsement follows the biotechnology company’s announcement that it has resubmitted the New Drug Application (NDA) for its dry eye disease treatment, Reproxalap. Aldeyra Therapeutics recently reported successful results from a Phase…